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Abstract
Background The United Kingdom Registry of Endocrine and Thyroid Surgeons is a national database holding details
on[ 28,000 parathyroidectomies.
Methods An extract (2004–2017) of the database was analysed to investigate the reported efficacy, safety and use of
intra-operative surgical adjuncts in targeted parathyroidectomy (tPTx) and bilateral neck exploration (BNE) for adult,
first-time primary hyperparathyroidism (PHPT).
Results 50.9% of 21,738 cases underwent tPTx. Excellent short-term (median follow-up 35 days) post-operative
normocalcaemia rates were reported overall (tPTx 96.6%, BNE 94.5%, p\ 0.05) and in image-positive cases (tPTx
96.7%, BNE 96%, p\ 0.05). Intra-operative PTH improved overall normocalcaemia rates (tPTx 97.8% vs 96.3%,
BNE 95% vs 94.4%: both p\ 0.05). Intra-operative nerve monitoring reduced vocal cord (VC) dysfunction in
image-positive tPTx, but not in BNE (97.8% vs 93.2%, p\ 0.05). Complications were higher following BNE (7.4%
vs 3.8%, p\ 0.05), especially hypocalcaemia (5.3% vs 2%, p\ 0.05). There was no difference in rates of subjective
dysphonia following tPTx or BNE (2.4% vs 2.3%, p[ 0.05), nor any difference in VC dysfunction when formally
examined (4.9% vs 4.1%, p[ 0.05).
Conclusions In image-positive, first time, adult PHPT cases, tPTx is as safe and effective as BNE, with both
achieving excellent short-term results with minimal complications.
Introduction
The United Kingdom Registry of Endocrine and Thyroid
Surgery (UKRETS) is a multi-centre, multi-disciplinary
(General, Otolaryngology, Oral and Maxillofacial, Trans-
plant and Vascular surgeons) database. It is the world’s
largest endocrine surgery database and is maintained by the
British Association of Endocrine and Thyroid Surgeons
(BAETS) members.
UKRETS has recognised potential deficiencies in care,
including under-diagnosis and heterogeneous practise
across the United Kingdom (UK). Therefore, the National
Institute for Health and Care Excellence (NICE) have
published guidelines on the management of primary
hyperparathyroidism (PHPT) in the UK [1].
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Targeted parathyroidectomy (tPTx) in selected patients,
with pre-operative localisation and intra-operative
parathyroid hormone (ioPTH), have led to well-docu-
mented reductions in operating time and post-operative
complications (especially hypocalcaemia) [2–5]. However,
there is the potential to miss multiglandular disease (MGD)
[6, 7], leading to recurrences. ioPTH during tPTx may
mitigate this risk, but its benefit in first-time parathy-
roidectomy remains debatable due to its cost, only mod-
erately high specificity in identifying those cases with
remaining abnormal tissue following adenoma excision [8],
and marginal improvement in cure [5]. A literature review
by Morris et al. [9] demonstrated that in a case of localised
PHPT, ioPTH increased the success rate of tPTx from 96.3
to 98.8%, whilst incurring an approximate additional cost
of 4% to the procedure. However, the authors did also
conclude that there were institution specific factors that
influenced the value of ioPTH.
With this in mind, a review of parathyroid surgery
recorded in the UKRETS was undertaken.
Aims
This study investigated the recorded efficacy and safety of
tPTx and bilateral neck exploration (BNE) with and with-
out surgical adjuncts in first-time PHPT cases from the
UKRETS.
Material and methods
Access to UKRETS was granted through the BAETS
executive committee in February 2018, for data from 2004
to 2017. Patient consent is obtained by surgeons to collect
and anonymously analyse data in UKRETS along General
Data Protection Regulation requirements. Clinical data are
uploaded by surgeons, but the dataset has not been exter-
nally validated. The data fields for parathyroid surgery are
available in the appendix of the Fifth National Report [9].
The lead author (HI) analysed the database.
Adults (C 18 years old) undergoing first-time parathy-
roidectomy for sporadic PHPT between 2004 and 2017
were included. Cases with illogical/inaccurate data (e.g.
age[ 100 years old) and cases not specified as first-time
surgeries were excluded. Cases with incomplete outcome
data were excluded from specific sub-analyses to prevent
skewing of interpretation. Missing data rates varied across
outcomes, so the denominator (total number of cases
analysed) varied depending on the outcome in question.
The recorded surgical technique (tPTx or BNE),
adjuncts and number of glands removed were analysed.
tPTx cases converted to BNE were analysed as BNE.
Complication rates and their nature were analysed. The
method (US, indirect or direct laryngoscopy) by which
formal vocal cord (VC) function was examined is not
specified in UKRETS.
UKRETS does not record operating centre or operative
findings, therefore, it was not possible to explain why
(failure to identify adenoma, identifying two ipsilateral
adenomas, or failure of ioPTH to fall below 50% of
baseline) some tPTx cases were converted to BNE. Neither
does it record decision-making on ioPTH or ioNM use,
availability of ioPTH/ioNM or operative approach (tPTx or
upfront BNE). Therefore, no comments or inferences on
these topics were made.
Definitions
BAETS [8] defines tPTx as ‘‘surgery that may include
mini-incision open techniques, endoscopic methods or even
unilateral neck exploration (UNE)’’, but UKRETS does not
distinguish between these techniques.
‘‘Image-positive’’cases where pre-operative localisation
modalities (ultrasonography (US) and/or nuclear medicine
(NM) and/or computed tomography (CT)/magnetic reso-
nance imaging (MRI)) identified target gland(s). UKRETS
does not record of the number or location(s) of the target
gland(s).
‘‘Hypocalcaemia’’ low serum corrected cal-
cium\ 2.1 mmol/L or ionized serum cal-
cium\ 1.2 mmol/L at first post-operative day.
‘‘Normocalcaemia’’ was defined as the absence of
hypocalcaemia and persistent hypercalcaemia at the first
post-operative visit.
‘‘Subjective dysphonia’’ the subjective (assessed by the
surgeon) presence of voice change at the first post-opera-
tive visit.
Statistical analysis
Descriptive statistics are reported as medians with
interquartile ranges (IQR; 25–75%), unless stated other-
wise. Medians were used to avoid central tendencies being
affected by outlying values.
Differences between groups and categorical variables
were calculated with the Mann–Whitney U and Fisher’s
exact test, respectively. P-values of\ 0.05 were consid-
ered statistically significant.
GraphPad Prism, version 8.0.1 (GraphPad Software,
7825 Fay Avenue, Suite 230, La Jolia, CA 92,037, USA)
was utilised for statistical analyses and Microsoft Excel,




After applying exclusions, there were 21,738 first-time
PHPT cases between 2004 and 2017 (Fig. 1); 50.9%
(n = 11,062) underwent tPTx and 49.1% (n = 10,676)
BNE. 8.1% (867/10,676) were converted from tPTx to
BNE. Between 2004–07, BNE was most frequently uti-
lised, but since 2008, both techniques have been employed
equally (Fig. 2).
BNE and tPTx were performed in 52.2% (5570/10,676)
and 98.1% of image-positive cases (10,850/11,062),
respectively. It was not possible to analyse how many of
the converted cases were due to a failure of ioPTH levels to
drop, as UKRETS did record this. Overall, ioPTH was used
more frequently during tPTx (25%; 63/11,602) than BNE
(19.1%, 2044/10,676) (p\ 0.05). ioPTH use has risen
from 0% (0/20) of tPTx and 1.3% (1/77) of BNE in 2004 to
29.8% (354/1187) and 28.6% (317/1098) in 2017,
respectively.
On average, 1.25 glands were removed in image-posi-
tive BNEs, compared to 1.07 in image-positive tPTx and
1.34 glands in all (image-positive and -negative) BNEs
(Table 1).
ioNM use was documented in 3151 cases: 17.5% of
tPTx (1732/9851) versus 15.4% of BNE cases (1419/9198)
(p\ 0.05). By 2017, ioNM was used in 34.1% of tPTx
(405/1187) and 29.8% of BNE cases (327/1098). There
were 1296 parathyroidectomies (6%; 1296/21,738) where
ioNM use was documented with a formal post-operative
VC functional outcome. ioNM was NOT used, but with a
formal post-operative VC functional outcome in 2209
parathyroidectomies (10.2%; 2209/21,738). More cases
had normal post-operative VC function following tPTx
with ioNM (97.8%; 657/672), than tPTx without ioNM
(93.2%; 1112/1193) (p\ 0.05). There was no difference in
VC function with or without ioNM in BNE cases (Table 2).
This group represents only 6% of the dataset due to the
infrequent use of ioNM and incomplete datasets.
There was no difference in rates of subjective dysphonia
following tPTx or BNE (2.4%; 219/9003 vs 2.3%;
212/9093, p[ 0.05). There was no difference between
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tPTx and BNE in VC dysfunction when formally examined
(4.9%, 93/1890 vs 4.1%, 70/1716, p[ 0.05) (Table 3).
Formal VC examination was either not performed or not
recorded in most cases (83.4%; 18,132/21,738).
The median time to first post-operative visit was 35 days
(IQR 19–51). Normocalcaemia rate was higher following
tPTx (96.6%; 8375/8664) than BNE (94.5%; 8254/8735)
(p\ 0.05). Normocalcaemia following tPTx was higher
with ioPTH (97.8%; 2291/2343) versus without ioPTH
(96.3%; 6084/6321) (p\ 0.05). There was no difference in
normocalcaemia rates following BNE with or without
ioPTH (95.0%; 1603/1688 vs 94.4%; 6651/7047, p[ 0.05)
(Table 4).
Image-positive tPTx had higher normocalcaemia rates
than BNE (96.7%; 8126/8397 vs 96.0%; 4131/4305)
(p\ 0.05) and especially when ioPTH was used (97.8%;
2200/2249 vs 96.1%; 730/760) (p\ 0.05). There was no
difference in normocalcaemia rates between image-posi-
tive tPTx (96.4%; 5924/6148) and BNE (96.0%;
3401/3545) without ioPTH. Normocalcaemia rates fol-
lowing BNE overall were lower than those in image-pos-
itive BNE (94.5%; 6651/7047 vs 96.0%; 3401/3545)
(p\ 0.05) (Table 4). Missing data represented 17.4%
(3430/21,738) of cases.
Overall, BNE had a higher complication rate than tPTx
(7.4%; 786/10,676 vs 3.8%; 417/11,062) (p\ 0.05),
mostly due to hypocalcaemia (5.3%; 533/10,131 vs 2.0%;
211/10,360) (Table 5).
Image-positive BNE had higher complication rates than
image-positive tPTx (4.9%; 274/5570 vs 3.5%;
376/10,850) (p\ 0.05). Wound infection and hypocal-
caemia rates were lower following image-positive tPTx
compared to image-positive BNE (Table 6). Analysis of
image-positive cases where only one gland was removed
Table 1 Number of parathyroid glands removed per parathyroidectomy
No. of glands removed Image-positive BNE
(total n = 5570)
Image negative BNE
(total n = 4029)
Image-positive tPTx
(total n = 10,850)
0 166 (3.0) 107 (2.7) 58 (0.5)
1 4043 (72.6) 2484 (61.7) 9916 (91.4)
2 1063 (19.1) 871 (21.6) 667 (6.1)
3 181 (3.2) 388 (9.6) 70 (0.6)
3.5 51 (0.9) 93 (2.3) 33 (0.3)
4 20 (0.4) 39 (1.0) 11 (0.1)
Total number of glands removed 6971 5872 11,620
Values in parentheses are percentages
Table 2 Rates of normal vocal cord movement following tPTx and BNE in UKRETS with and without ioNM
With ioNM Without ioNM P value
N (%)
Image-positive tPTx 657/672 (97.8) 1112/1193 (93.2) \ 0.05
Image-positive BNE 386/398 (97) 576/604 (95.4) NS
Image negative BNE 219/226 (97) 398/412 (96.7) NS
Total no. of cases 1296/21,738 (6) 2209/21,738 (10.2) \ 0.05
Table 3 Incidence and missing data for subjective dysphonia and abnormal VC assessment following parathyroidectomy, comparing outcomes
from tPTx and BNE
tPTx (%) BNE (%) P value
Subjective dysphonia 219/9003 (2.4) 212/9093 (2.3) NS
Post-op VC check done 1890/11,062 (17.1) 1716/10,676 (16.1) NS
Post-op abnormal VC check 93/1890 (4.9) 70/1716 (4.1) NS
World J Surg
123
that resulted in hypocalcaemia demonstrated tPTx had a
lower rate that BNE (2.6%; 159/6062 vs 3.5%; 141/4043,
p\ 0.05).
Of 744 hypocalcaemic cases, 434 (58.3%) had records
of whether or not vitamin D/calcium supplements were still
being taken at the first post-operative visit. Fewer tPTx
cases were taking supplements compared to BNE cases
(13.1%; 18/137 vs 24.3%; 72/296, p\ 0.05). Unfortu-
nately, there is no long-term hypocalcaemia data.
21.2% of tPTxs (2068/9838) were discharged on the
same day, versus 11.2% of BNEs (1089/9787) (p\ 0.05).
There was no difference in discharge frequency on the first
post-operative day (tPTx 66.2%; 6514/9838 vs BNE
66.4%; 6500/9787, p[ 0.05). Length of stay greater than
one day was more common in BNE than tPTx (22.5%;
2198/9787 vs 12.8%; 1256/9838) (p\ 0.05).
Discussion
This analysis of 21,738 adult first-time PHPT cases
between 2004 and 2017 is the largest reported multi-centre,
multidisciplinary review of parathyroid surgery in the
world. 11,602 (50.9%) underwent tPTx, comparable to
other registry studies; Kazaure et al. [10] (55.9%,
n = 3592) and Bergenfelz et al. [11] (39%, n = 1050).
Despite positive pre-operative localisation, 52% of
patients underwent BNE. 8% of these (867/10,676) were
initially treated as tPTx then converted to BNE, inferring
Table 4 Rate of normocalcaemia following parathyroidectomy comparing tPTx and BNE with and without ioPTH in overall and image-positive
cases
tPTx (%) BNE (%) P value
Overall 8375/8664 (96.6) 8254/8735 (94.5) \ 0.05
With ioPTH 2291/2343 (97.8) 1603/1688 (95.0) \ 0.05
Without ioPTH 6084/6321 (96.3) 6651/7047 (94.4) \ 0.05
Image ? ve tPTx (%) Image ? ve BNE (%)
Overall 8126/8397 (96.7) 4131/4305 (96.0) \ 0.05
With ioPTH 2200/2249 (97.8) 730/760 (96.1) \ 0.05
Without ioPTH 5926/6148 (96.4) 3401/3545 (96.0) NS
Table 5 Overall complications following tPTx and BNE
Complications tPTx (%) BNE (%) P value
Overall complication rate 417/11,062 (3.8) 786/10,676 (7.4) \ 0.05
Wound infection 28/11,062 (0.3) 47/10,676 (0.4) \ 0.05
Haematoma requiring RTT 36/10,505 (0.3) 44/10,195 (0.4) NS
Hypocalcaemia (NOS) 211/10,360 (2.0) 533/10,131 (5.3) \ 0.05
Other complications 142/11,062 (1.3) 162/10,676 (1.5) NS
NS not significant, NOS not otherwise specified, RTT return to theatre
Table 6 Complications following parathyroidectomy in image positive cases
Complications Image ? ve tPTx (%) Image ? ve BNE (%) P value
Overall complication rate 376/10,850 (3.5) 274/5570 (4.9) \ 0.05
Wound infection 23/10,850 (0.2) 26/5570 (0.5) \ 0.05
Haematoma requiring RTT 36/10,310 (0.3) 14/3357 (0.4) NS
Hypocalcaemia (NOS) 203/10,188 (2.0) 165/3335 (4.9) \ 0.05
Other complications 114/10,850 (1.1) 69/5570 (1.2) NS
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that 44% of image-positive cases underwent upfront BNE.
It was not possible to report if cases underwent BNE due to
multiple glands being identified on pre-operative localisa-
tion, which may explain why a high proportion of cases
underwent BNE with positive localisation. Other potential
hypotheses include surgeon preference on operative tech-
nique, variable imaging quality and patient factors (high
body mass index) and shared decision-making.
Normocalcaemia rates following both techniques were
excellent and are comparative to reports by Jinih et al. [12]
(tPTx 96.4%, BNE 96.7%; no clear definition of ‘‘cure’’)
and Ospina et al. [13] (tPTx 98%, BNE 97%; variable
definition of ‘‘cure’’). The authors acknowledge that
‘‘normocalcaemia’’ in this study does not equate to the
American Association of Endocrine Surgeons (AAES)
definition of ‘‘cure’’ [2]. The UKRETS does not currently
collect data on long-term (more than six months) follow-up
data. Normocalcaemia rates for image-positive cases sug-
gestive of single gland disease managed by tPTx and BNE
(96.7% vs 96.0%), although statistically significant, were
marginal and so of questionable clinical importance. This
supports the recommendation of discussing both operative
approaches in image-positive patients [1].
Normocalcaemia rates following tPTx were excellent
with (97.8%) or without (96.4%) ioPTH. These fig-
ures underestimate the benefit of ioPTH, as cases converted
from tPTx to BNE, possibly due to failure of ioPTH to fall
below 50% of baseline, were analysed as BNE, and so not
included in the analysis of tPTx. Ishii et al. [14] reported
overall cure at six months was higher (99.3% vs 98.1%,
p\ 0.05) and recurrence lower (0.2% vs 1.5%, p\ 0.05)
when ioPTH was utilised with minimally invasive
parathyroidectomy. They found ioPTH was less likely to be
utilised in image concordant (versus image discordant)
cases. The low record of ioPTH in UKRETS suggests it is
still not being routinely used. However, the database
demonstrated that the rate of ioPTH was at its highest in
2017. NICE [1] does not recommend routine use of ioPTH
in first-time surgery, which seems justified, given the extra
cost, for only marginal improvements in normocalcaemia
rates. Neither NICE or AAES currently recommend routine
use of ioNM [1, 2]. UKRETS demonstrated, in a small
subset of cases (6%) which reported ioNM use with a
documented post-operative VC assessment outcome, there
were fewer abnormal VC function following tPTx, but not
BNE. It is unclear why ioNM should be beneficial in tPTx
but not BNE, though limited dissection during tPTx may
compromise a satisfactory view of the recurrent laryngeal
nerve. ioNM was used more frequently in tPTx than BNE,
probably due to increasing popularity of tPTx coinciding
with increasing availability of ioNM. Given the small
proportion of cases with reported ioNM use, these results
may not be representative of or applicable to overall care.
However, UKRETS demonstrated an association between
ioNM in tPTx and improved rates of post-operative normal
VC function.
Overall and image-positive complication rates were
significantly lower following tPTx versus BNE. These
figures are similar to Jinih et al. [12] (tPTx 3.7%, BNE
17.1%). Bergenfelz et al.’s [11] review of the SQRTPA
database reported overall complication rates of 3.4%
(n = 92).
It was not possible to ascertain if hypocalcaemia was
temporary or permanent or if there was a cause such as
hungry bone syndrome. Hypocalcaemia rates were signif-
icantly higher following BNE than tPTx, but this study
found that more glands were excised during BNE, so this
higher rate is expected.
Abnormal VC function following tPTx (4.9%) was
higher than Jinih et al.’s [12] and Ishii et al.’s [14] num-
bers. The high rate of missing data for VC function meant
it was difficult to draw any definitive conclusions. Sub-
jective dysphonia rate was 2.4% (no difference between
techniques). However, subjective assessment is inaccurate,
variable and may potentially underestimate actual VC
dysfunction [15, 16]. Rates of formally assessed post-op-
erative abnormal VC function were 4.9% following tPTx
and 4.1% following BNE (p[ 0.05), but it is not fair to
compare these figures against subjective dysphonia rates as
there may be other reasons for dysphonia (injury to
external branch of superior laryngeal nerve, vocal cord
oedema, surgical scar tissue, etc.).
BAETS do not endorse same-day discharge following
thyroidectomy due to potential airway obstruction sec-
ondary to post-operative haematoma [17]. This has influ-
enced parathyroidectomy practise and may explain the
similar proportion of overnight stays following tPTx and
BNE. BNEs had longer post-operative stays which may be
partially explained by the higher hypocalcaemia rate in this
group, where normalising calcium may have required
intravenous replacements, delaying discharge.
Strengths and limitations
Registries are useful to answer certain questions that are
not suitable for randomized clinical trials. This registry
study provides the best insight into parathyroidectomy
outcomes across the UK. Multi-disciplinary surgeons have
contributed from both small and large volume centres,
reducing the risk of skewed data, and allowing comparison
with recognised guidelines [1, 2]. The large number of
cases reduces the risk of bias/errors that are inherent from
small sample sizes, and highlights statistically significant
differences between groups with similar clinical outcomes.
It is important to consider these results carefully, as the
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number of patients needed to treat to achieve comparable
results may not justify expensive interventions for only
marginal benefits.
Limitations include the significant amount of missing
data, design flaws of data collection, potential self-report-
ing bias, coding errors, voluntary nature of uploading cases
and lack of external validation (though this is currently
being addressed). The results only allowed a median fol-
low-up of 35 days, meaning long-term outcomes (cure,
persistent disease and recurrence rates) were not recorded,
limiting its use when comparing techniques. ‘‘Targeted
parathyroidectomy’’ as per UKRETS, encompasses various
surgical techniques, which may affect outcomes. Selection
criteria for surgery, symptoms, complications or severity of
PHPT are not recorded and therefore not assessed.
An example of potential coding errors is highlighted in
the number of glands removed by operative technique. An
average of 1.07 glands was excised during tPTx, most
likely because UNEs are coded as tPTx in UKRETS. It is
not possible to explain why 3, 3.5 or 4 glands were excised
during tPTx, as UKRETS does not record pre-operative
findings or histology of excised glands, though presumably
these may be coding errors.
Factors confounding the interpretation of results include
the fact that only selected patients underwent tPTx, there-
fore the incidence of MGD is likely to be higher in cases
undergoing BNE, where more glands were excised. This
affects comparisons of normocalcaemia and hypocal-
caemia rates between tPTx and BNE. However, this study
did demonstrate that in image-positive cases where only
one gland was removed, BNE had a higher rate of post-
operative hypocalcaemia than tPTx.
Interpretation of localisation results are limited. The
number anatomical location of pathological glands or
whether the results corresponded to operative findings are
not recorded. Hence any inferences about the concordance
or discordance of localisation modalities cannot be made.
This study has highlighted areas of the registry that can
be updated to improve data collection and analysis.
Conclusions
This study has reported on the largest parathyroid registry
in the world; 21,738 cases of first-time primary hyper-
parathyroidism treated between 2004 and 2017. This study
has demonstrated that in image-positive cases, tPTx is as
safe and effective as BNE, with both achieving excellent
results with minimal complications.
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